Ala54Thr polymorphism of fatty acid-binding protein 2 gene and fasting blood lipids: A meta-analysis

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 461-467

  Zhao, Tongfeng ^a   Nzekebaloudou, Marius ^a   lv, Jing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Blood lipids; Fatty acid binding protein 2; Meta analysis; Polymorphism

Indexed keywords

ALANINE; CHOLESTEROL; FATTY ACID BINDING PROTEIN 2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THREONINE; TRIACYLGLYCEROL;

ALLELE; ARTICLE; DIET RESTRICTION; DYSLIPIDEMIA; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALANINE; ALLELES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FATTY ACID-BINDING PROTEINS; FEMALE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; THREONINE;

EID: 77953229834     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.11.049     Document Type: Article

References (47)

1. Menown I.B., Murtagh G., Maher V., et al. Dyslipidemia therapy update: the importance of full lipid profile assessment. Adv Ther 2009, 7:711-718.
2. Garg A., Simha V. Update on dyslipidemia. J Clin Endocrinol Metab 2007, 5:581-589.
3. Bosse Y., Chagnon Y.C., Despres J.P., et al. Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Quebec Family Study. J Lipid Res 2004, 3:419-426.
4. Clifton P., Colquhoun D., Hewat C., et al. Dietary intervention to lower serum cholesterol. Aust Fam Physician 2009, 6:424-429.
5. Gastaldi M., Diziere S., Defoort C., et al. Sex-specific association of fatty acid binding protein 2 and microsomal triacylglycerol transfer protein variants with response to dietary lipid changes in the 3-mo Medi-RIVAGE primary intervention study. Am J Clin Nutr 2007, 6:1633-1641.
6. Helwig U., Rubin D., Klapper M., et al. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability. Metabolism 2007, 6:723-731.
7. Baier L.J., Sacchettini J.C., Knowler W.C., et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995, 95:1281-1287.
8. de Luis D.A., Sagrado M.G., Aller R., Izaola O., Conde R. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors. Horm Metab Res 2007, 11:830-834.
9. Baier L.J., Bogardus C., Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996, 271:10892-10896.
10. Levy E., Menard D., Delvin E., et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 2001, 276:39679-39684.
11. Albala C., Villarroel A., Santos J.L., et al. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res Clin Pract 2007, 2:245-250.
12. Albala C., Santos J.L., Cifuentes M., et al. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res 2004, 2:340-345.
13. Georgopoulos A., Aras O., Noutsou M., Tsai M.Y. Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene. J Clin Endocrinol Metab 2002, 8:3735-3739.
14. Galluzzi J.R., Cupples L.A., Otvos J.D., et al. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis 2001, 2:417-424.
15. Berthier M.T., Couillard C., Prudhomme D., et al. Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men. Obes Res 2001, 11:668-675.
16. Brown M.D., Shuldiner A.R., Ferrell R.E., et al. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism 2001, 9:1102-1105.
17. Georgopoulos A., Bloomfield H., Collins D., et al. Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT). Atherosclerosis 2007, 1:169-174.
18. Erkkila A.T., Lindi V., Lehto S., et al. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease. Nutr Metab Cardiovasc Dis 2002, 2:53-59.
19. Tahvanainen E., Molin M., Vainio S., et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 2000, 2:317-325.
20. Georgopoulos A., Aras O., Tsai M.Y. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 2000, 85:3155-3160.
21. Sipilainen R., Uusitupa M., Heikkinen S., Rissanen A., Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 1997, 8:2629-2632.
22. de Luis D.A., Sagrado M.G., Aller R., et al. Ala54Thr polymorphism of fatty acid binding protein 2. Role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients. Obes Surg 2009, 12. [Epub ahead of print].
23. Oguri M., Kato K., Yokoi K., et al. Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. Atherosclerosis 2009, 19. [Epub ahead of print].
24. Takakura Y., Yoshioka K., Umekawa T., et al. Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diabetes Res Clin Pract 2005, 1:36-42.
25. Ishii T., Hirose H., Kawai T., et al. Effects of intestinal fatty acid-binding protein gene Ala54Thr polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men. Metabolism 2001, 11:301-307.
26. Kim C.H., Yun S.K., Byun D.W., et al. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men. Metabolism 2001, 4:473-476.
27. Hayakawa T., Nagai Y., Nohara E., et al. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects. Metabolism 1999, 5:655-657.
28. Xiang K.S., Zheng T.S., Jia W.P., et al. The association of Ala54Thr variant of intestinal Fatty acid binding protein gene with general regional adipose tissue deposits. Chin Med Sci J 1999, 1:46-51.
29. Chang X.T., Wang Z.H., Hou L.J., et al. Association between codon 54 polymorphism of intestinal fatty acid-binding protein 2 gene and plasma lipids in middle-aged and old populations. J Clin Rehabil Tissue Eng Res 2008, 7:1397-1400.
30. Wang J., Si Q., Fu Y., Wang X.D. Polymorphism of the fatty acid-binding protein 2 gene in patients with coronary heart disease. Int J Emerg Crit Care Med 2006, 4:1352-1355.
31. Chamberlain A.M., Schreiner P.J., Fornage M., et al. Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Metabolism 2009, 9:1222-1228.
32. Martinez-Lopez E., Ruíz-Madrigal B., Hernández-Canaveral I., Panduro A. Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjects. Diab Vasc Dis Res 2007, 3:235-236.
33. Perez-Bravo F., Fuentes M., Angel B., et al. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile. Acta Diabetol 2006, 4:93-98.
34. Vimaleswaran K.S., Radha V., Mohan V. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism 2006, 9:1222-1226.
35. Lefevre M., Lovejoy J.C., Smith S.R., et al. Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism 2005, 12:1652-1658.
36. Nakanishi S., Yamane K., Kamei N., Okubo M., Kohno N. The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans. Diabetes Obes Metab 2004, 1:45-49.
37. Lei H.H., Coresh J., Shuldiner A.R., Boerwinkle E., Brancati F.L. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 1999, 9:1868-1872.
38. Welton N.J., Caldwell D.M., Adamopoulos E., Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol 2009, 9:1158-1165.
39. Fleiss J.L. The statistical basis of meta-analysis. Stat Methods Med Res 1993, 2:121-145.
40. Bax L., Yu L.M., Ikeda N., Tsuruta H., Moons K.G.M. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006, 6:50.
41. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM. MIX: comprehensive free software for meta-analysis of causal research data. Version 1.7; 2008. http://mix-for-meta-analysis.info/.
42. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simples, graphical test. BMJ 1997, 315:629-634.
43. Yong D., QingQing W., Hua L. Association of uteroglobin G38A polymorphism with IgA nephropathy: a meta-analysis. Am J Kidney Dis 2006, 1:1-7.
44. Haynes W.G. Triglyceride-rich lipoproteins and vascular function. Arterioscler Thromb Vasc Biol 2003, 2:153-155.
45. Guettier J.M., Georgopoulos A., Tsai M.Y., et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab 2005, 3:1705-1711.
46. Galluzzi J.R., Cupples L.A., Meigs J.B., et al. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study. Diabetes Care 2001, 7:1161-1166.
47. Vassileva G., Huwyler L., Poirier K., Agellon L.B., Toth M.J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 2000, 14:2040-2046.